AnTolRx

0 followers


AnTolRx’s vision is to build a platform that selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mark Carthy
Founder & CEO

Mark Carthy

Collapse
No reports!